Genmab A/S (GMAB) PT Raised to $36 at SunTrust; 'Product Potential, Pipeline and Platform'
Tweet Send to a Friend
SunTrust analyst Asthika Goonewardene raised the price target on Genmab A/S (NASDAQ: GMAB) to $36.00 (from $30.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
